North America Pulmonary Devices Market Growth and Analysis by 2027
North America Pulmonary Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Therapeutic Devices, Consumables and Accessories, Diagnostic Devices, and Monitoring Devices); Application (Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, Infectious Diseases, and Others); and End User (Hospitals, Homecare Settings, and Ambulatory Care Centers) and Country
- Report Date : Sep 2020
- Report Code : TIPRE00013998
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 118
The North America pulmonary devices market is expected to reach US$ 16,637.44 million by 2027 from US$ 7,581.04 million in 2019; it is estimated to grow at a CAGR of 10.3% from 2020 to 2027.
Increasing prevalence of respiratory diseases and growing number of COVID-19 in the region are the key factors driving the growth of pulmonary devices. However unfavorable reimbursement scenario is the major factor hindering the market growth in North America.
Pulmonary or respiratory devices are used to remove mucus and secretions from the airways or the respiratory tract. These medical devices are focused on diagnosis, control, treatment, management, and evaluation of the problems associated with respiratory tract.
Manufacturers in the pulmonary devices market are ramping up their focus on the adoption of various strategies, such as product innovation, product launches, and approvals, as well as R&D investment for advancements in ventilators, along with merger and acquisition as their developmental strategies to maintain the competitive environment in the market.
For instance, in January 2020, Masimo Corporation acquired Connected Care Business from NantHealth (US). This acquisition will support Masimo to assist hospitals in providing constant care through connectivity, automation, and innovative noninvasive monitoring technologies. Similarly, in April 2019, Inogen, Inc. introduced the Inogen One G5 portable oxygen concentrator with the highest oxygen production capacity per pound of weight, amounting to 1,260 ml. In May 2020, Philips partnered with Masimo. This partnership was aimed at integrating Masimo’s measurement technologies into select intellivue MX-Series multi-parameter monitors to help clinicians examine ventilation status and cerebral oximetry. In March 2019, ResMed acquired HB Healthcare Safety, a provider of home-based medical equipment for sleep and respiratory care devices.
The impact of the COVID-19 crisis is expected to further accelerate the growth of the respiratory devices market in North America. In addition, the threat will have a lasting impact on governments and regulatory agencies in terms of future preparedness when it comes to the next pandemic. Today, government is playing catch-up, swiftly intervening in an attempt to create alliances with manufacturers to handle the COVID-19 threat. In addition, international regulatory agencies are considering accelerated approval of certain respiratory devices.
Mexico Pulmonary Devices Market, Revenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
NORTH AMERICA PULMONARY DEVICES MARKET SEGMENTATION
By Type
- Therapeutic Devices
- Consumables and Accessories
- Diagnostic Devices
- Monitoring Devices
By Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Sleep Apnea
- Asthma
- Infectious Diseases
- Others
By End User
- Hospitals
- Home Care Settings
- Ambulatory Care Centers
By Country
- US
- Canada
- Mexico
Company Profiles
- ResMed
- Masimo
- Invacare Corporation
- Koninklijke Philips N.V.
- Getinge AB
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Application, and End User and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Pulmonary Devices Market – By Type
1.3.2 North America Pulmonary Devices Market – By Application
1.3.3 North America Pulmonary Devices Market– By End User
1.3.4 North America Pulmonary Devices Market – By Country
2. North America Pulmonary Devices Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Pulmonary Devices Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Pulmonary devices Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Pulmonary Devices Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Number of COVID-19 Cases
5.1.2 Increasing Prevalence of Respiratory Diseases
5.2 Key Market Restraints
5.2.1 Unfavourable Reimbursement Scenario
5.3 Key Market Opportunities
5.3.1 Strategic Activities by Manufacturers
5.4 Future Trends
5.4.1 Increasing Preference of Home Care Products
5.5 Impact Analysis
6. Pulmonary Devices Market – North America Analysis
6.1 North America Pulmonary Devices Market Revenue Forecasts and Analysis
7. North America Pulmonary Devices Market Analysis and Forecasts To 2027 – By Type
7.1 Overview
7.2 North America Pulmonary Devices Market, By Type 2019 & 2027 (%)
7.2.1 North America Pulmonary Devices Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.3 Therapeutic Devices
7.3.1 Overview
7.3.2 North America Therapeutic Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Consumables and Accessories
7.4.1 Overview
7.4.1.1 North America Consumables and Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Diagnostic Devices
7.5.1 Overview
7.5.2 North America Diagnostic Devices Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Monitoring Devices
7.6.1 Overview
7.6.2 North America Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Pulmonary Devices Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 North America Pulmonary Devices Market, By Application 2019 & 2027 (%)
8.2.1 North America Pulmonary Devices Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 COPD
8.3.1 Overview
8.3.2 North America COPD Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Asthma
8.4.1 Overview
8.4.2 North America Asthma Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Sleep Apnea
8.5.1 Overview
8.5.2 North America Sleep Apnea Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Infectious Diseases
8.6.1 Overview
8.6.2 North America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Others
8.7.1 Overview
8.7.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Pulmonary Devices Market Analysis – By End-User
9.1 Overview
9.2 North America Pulmonary Devices Market, By End-User 2019-2027 (%)
9.2.1 North America Pulmonary Devices Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Hospitals
9.3.1 Overview
9.3.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Homecare Settings
9.4.1 Overview
9.4.2 North America Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Ambulatory Care Centers
9.5.1 Overview
9.5.2 North America Ambulatory Care Centers Market Revenue and Forecasts to 2027 (US$ Mn)
10. Pulmonary Devices Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Pulmonary Devices Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Pulmonary Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Pulmonary Devices Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.4 North America: Pulmonary Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America: Pulmonary Devices Market, By End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Pulmonary Devices Market, by Country, 2019 & 2027 (%)
10.1.7 US: Pulmonary Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Pulmonary Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Pulmonary Devices Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US: Pulmonary Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US: Pulmonary Devices Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Pulmonary Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Pulmonary Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Pulmonary Devices Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada: Pulmonary Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada: Pulmonary Devices Market, End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Pulmonary Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Pulmonary Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Pulmonary Devices Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico: Pulmonary Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico: Pulmonary Devices Market, End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Pulmonary Devices Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 ResMed
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Masimo
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Invacare Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips N.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Getinge AB
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Pulmonary Devices Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 2. North America Pulmonary Devices Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Pulmonary Devices Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 4. North America: Pulmonary Devices Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. North America: Pulmonary Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 6. North America: Pulmonary Devices Market, By End User – Revenue and Forecast to 2027 (USD Million)
Table 7. US: Pulmonary Devices Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. US: Pulmonary Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. US: Pulmonary Devices Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada: Pulmonary Devices Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada: Pulmonary Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada: Pulmonary Devices Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico: Pulmonary Devices Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico: Pulmonary Devices Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico: Pulmonary Devices Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Glossary of Terms, Pulmonary Devices Market
LIST OF FIGURES
Figure 1. Pulmonary Devices Market Segmentation
Figure 2. North America Pulmonary Devices Market Overview
Figure 3. Therapeutics Segment Held Largest Share of Pulmonary Devices Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Pulmonary Devices Market - Leading Country Markets (US$ Mn)
Figure 6. Pulmonary devices Market - North America PEST Analysis
Figure 7. Pulmonary devices Market Impact Analysis of Driver and Restraints
Figure 8. North America Pulmonary Devices Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Pulmonary Devices Market, By Type 2019 & 2027 (%)
Figure 10. North America Therapeutic Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Consumables and Accessories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Diagnostic Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Monitoring Devices Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Pulmonary Devices Market, By Application 2019 & 2027 (%)
Figure 15. North America COPD Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Asthma Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Sleep Apnea Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Pulmonary Devices Market, by End-User 2019 & 2027 (%)
Figure 21. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Ambulatory Care Centers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America: Pulmonary Devices Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. North America: Pulmonary Devices Market Revenue and Forecast to 2027 (USD Million)
Figure 26. North America: Pulmonary Devices Market, by Country, 2019 & 2027 (%)
Figure 27. US: Pulmonary Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Canada: Pulmonary Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Mexico: Pulmonary Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Impact of COVID-19 Pandemic on Pulmonary Devices Market in North American Countries
The List of Companies - North America Pulmonary Devices Market
- ResMed
- Masimo
- Invacare Corporation
- Koninklijke Philips N.V.
- Getinge AB
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Sep 2020
Infectious Disease In vitro Diagnostics Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application (HIV or AIDS, Tuberculosis, Hepatitis B and C, Malaria, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Blood Bank, and Others), and Geography
Sep 2020
Donor Blood Components Market
Size and Forecast (2021–2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppression and Oncology), Application (Anemia Management, Thrombocytopenia Treatment, Coagulopathy Correction, Supportive Care During Chemotherapy, Surgery, and Others), Age Group (Adult and Child), End User (Hospitals, Oncology Centers, Transplant Centers, Ambulatory Surgical Centers, and Others), and Geography
Sep 2020
Aesthetic Injectable Devices Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product (Dermal Filler, Botulinum Toxin and Others), Dermal Fillers (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate, Fat Fillers, and Others), Device Type (Microcannulas, Pre-Filled Syringes, Mesotherapy Guns, and Others), Application (Facial Line Correction, Face Lift, Lip Treatment, Anti-Ageing and Wrinkle Treatment, Acne and Scar Treatment, Stretch Marks, and Others), Age Group (Up to 30, 31-40, 41-50, 51-60, and More Than 60), Gender (Female and Male), End User (Medical Spas, Dermatology Clinics, Hospitals, and Others), and Geography
Sep 2020
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Prescription Drugs Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Product Type (Branded and Generics), Drug Type (Small Molecule and Biologics and Biosimilar), Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Diseases, Metabolic Diseases, Respiratory Diseases, Immunology, and Others), Route Of Administration (Oral, Injectable, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Regenerative Dentistry Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Natural and Synthetic), Technology (Tissue Engineering, Stem Cell Therapy, and Others), Application (Periodontal Regeneration, Endodontic Regeneration, Tooth Reconstruction, Bone Regeneration, and Others), Age Group (Adult and Pediatric), End User (Dental Clinics, Hospital, and Others), and Geography
Sep 2020
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Sep 2020
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
Get Free Sample For